Association of cytokine gene polymorphisms and liver fibrosis in chronic hepatitis B

Journal of Gastroenterology and Hepatology (Australia)

Volumn 23, Issue 5, 2008, Pages 783-789

  Chan, Henry L Y ^a,b   Tse, Ada M L ^b   Chim, Angel M L ^b   Wong, Vincent W S ^b   Choi, Paul C L ^a   Yu, Jun ^b   Zhang, Mingdong ^b   Sung, Joseph J Y ^b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cirrhosis; Hepatitis B virus; Interleukin; Single nucleotide polymorphism; Tumor necrosis factor

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CHINESE; CHRONIC HEPATITIS; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HEPATITIS B; HUMAN; LIVER FIBROSIS; LIVER NECROSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCORING SYSTEM;

EID: 42049105618     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2007.05110.x     Document Type: Article

References (38)

1. Chan HLY, Ghany MG, Lok ASF. Hepatitis B. In : Schiff ER, Sorrell MF, Madrey WC, eds. Schiff's Diseases of the Liver, 8th edn. New York : Lippincott-Raven Publishers, 1998 757 92.
2. Bataller R, North KE, Brenner DA. Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal. Hepatology 2003 37 : 493 503.
3. Chan HLY, Wong ML, Hui AY, Hung LCT, Chan FKL, Sung JJY. Genotype C hepatitis B virus takes a more aggressive disease course before hepatitis B e antigen seroconversion as compared to genotype B hepatitis B virus. J. Clin. Microbiol. 2003 41 : 1277 9.
4. Chan HLY, Tsang SWC, Liew CT et al. Viral genotype and hepatitis B virus DNA levels are correlated with histologic liver damage in HBeAg-negative chronic hepatitis B virus infection. Am. J. Gastroenterol. 2002 97 : 406 12.
5. Chan HLY, Hui Y, Wong ML et al. Genotype C hepatitis B virus infection is associated with increased risk of hepatocellular carcinoma. Gut 2004 53 : 1494 8.
6. Redpath S, Ghazal P, Gascoigne NR. Hijacking and exploitation of IL-10 by intracellular pathogens. Trends Microbiol. 2001 9 : 86 92.
7. Grove J, Daly AK, Bassendine MF, Gilvarry E, Day CP. Interleukin 10 promoter region polymorphisms and susceptibility to advanced alcoholic disease. Gut 2000 46 : 540 5.
8. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996 87 : 2095 147.
9. Vassali P. The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 1992 10 : 411 52.
10. Takamatsu M, Yamauchi M, Maezawa Y, Saito S, Maeyama S, Uchikoshi T. Genetic polymorphism of interleukin-1 beta in association with the development of alcoholic liver disease in Japanese patients. Am. J. Gastroenterol. 2000 95 : 1305 11.
11. Donaldson P, Agarwal K, Craggs A, Craig W, James O, Jones D. HLA and interleukin-1 gene polymorphism in primary biliary cirrhosis: association with disease progression and disease susceptibility. Gut 2001 48 : 397 402.
12. Tanaka A, Quarranta S, Mattalia A et al. The tumor necrosis factor-α promoter correlates with progression of primary biliary cirrhosis. J. Hepatol. 1999 30 : 826 9.
13. Yee LJ, Tang J, Herrera J, Kaslow RA, van Leeuwen DJ. Tumor necrosis factor gene polymorphism in patients with cirrhosis from chronic hepatitis c virus infection. Gene Immun. 2000 1 : 386 90.
14. Liaw YF, Sung JJ, Chow WC et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease. N. Engl. J. Med. 2004 351 : 1521 31.
15. Chan HLY, Leung NWY, Hui AY et al. A randomized, controlled trial of combination therapy for chronic hepatitis B: comparing pegylated interferon alfa-2b and lamivudine with lamivudine alone. Ann. Intern. Med. 2005 142 : 240 50.
16. Loeb KR, Jerome KR, Goddard J, Huang ML, Cent A, Corey L. High-throughput quantitative analysis of hepatitis B virus DNA in serum using the TaqMan fluorogenic detection system. Hepatology 2000 32 : 626 9.
17. Chan HLY, Chui AKK, Lau WY et al. Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantation. J. Med. Virol. 2002 68 : 182 7.
18. Ishak K, Baptista A, Bianchi L et al. Histological grading and staging of chronic hepatitis. J. Hepatol. 1995 22 : 696 9.
19. El-Omar EM, Carrington M, Chow WH et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000 404 : 398 402.
20. Chan HLY, Tse AML, Zhang MD et al. Genetic polymorphisms of interleukin-1-beta in association with sustained response to anti-viral treatment in chronic hepatitis B in Chinese. Aliment. Pharmacol. Ther. 2006 23 : 1703 11.
21. Tarlow JK, Blakemore AI, Lennard A et al. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum. Genet 1993 91 : 403 4.
22. Mangia A, Santoro R, Piatteli M et al. IL-10 haplotypes as possible predictors of spontaneous clearance of HCV infection. Cytokine 2004 25 : 103 9.
23. Shin HD, Park BL, Kim LH et al. Interleukin 10 haplotype associated with increased risk of hepatocellular carcinoma. Hum. Mol. Genet 2003 12 : 901 6.
24. El-Omar EM, Rabkin CS, Gammon MD et al. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 2003 124 : 1193 201.
25. Liu K, Muse SV. Powermarker: an integrated analysis environment for genetic marker analysis. Bioinformatics 2005 21 : 2128 9.
26. Rosenwasser LJ, Borish L. Genetics of atopy and asthma: the rationale behind promoter-based candidate gene studies (IL-4 and IL-10). Am. J. Respir. Crit. Care Med. 1997 156 : S152 5.
27. Eskdale J, Kube D, Tesch H, Gallagher G. Mapping of the IL-10 gene and further characterization of the 5′ flanking sequence. Immunogenetics 1997 46 : 120 8.
28. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in teh interleukin-10 gene promoter. Eur. J. Immunogenet. 1997 24 : 1 8.
29. Miyazoe S, Hamasaki K, Nakata K et al. Influence of interleukin-10 gene promoter polymorphisms on disease progression in patients chronically infected with hepatitis B virus. Am. J. Gastroenterol. 2002 97 : 2086 92.
30. Ben-Ari Z, Mor E, Papo O et al. Cytokine gene polymorphisms in patients infected with hepatitis B virus. Am. J. Gastroenterol. 2003 98 : 144 50.
31. Louis H, Le Moine O, Peny MO et al. Hepatoprotective role of interleukin 10 in galactosamine/lipopolysaccharide mouse liver injury. Gastroenterology 1997 112 : 935 42.
32. Louis H, Van Laethem JL, Wu W et al. Interleukin-10 controls neutrophilic infiltration, hepatocyte proliferation, and liver fibrosis induced by carbon tetrachloride in mice. Hepatology 1998 28 : 1607 15.
33. Nelson DR, Lauwers GY, Lau JY, Davis GL. Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonresponders. Gastroenterology 2000 118 : 655 60.
34. Hui AY, Chan HLY, Wong VWS et al. Identification of chronic hepatitis B patients without significant liver fibrosis by a simple noninvasive predictive model. Am. J. Gastroenterol. 2005 100 : 616 23.
35. Zhang PA, Li Y, Xu P, Wu JM. Polymorphisms of interleukin-1β and interleukin-1 receptor antagonist genes in patients with chronic hepatitis B. World J. Gastroenterol. 2004 10 : 1826 9.
36. Kim YJ, Lee HS, Yoon JH et al. Association of TNF-α promoter polymorphisms with the clearance of hepatitis B virus infection. Hum. Mol. Genet 2003 12 : 2541 6.
37. Lu LP, Li XW, Liu Y et al. Association of -238/A polymorphism of tumor necrosis factor-alpha gene promoter region with outcomes of hepatitis B virus infection in Chinese Han population. World J. Gastroenterol. 2004 10 : 1810 14.
38. Lemeshow S, Hosmer DW, Klar J, Lwanga SK. Adequacy of Sample Size in Health Studies. New York : Wiley Publishing, 1990.